Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Iron Lady Tomatoes Resist Three Fungal Diseases

Published: Monday, March 18, 2013
Last Updated: Monday, March 18, 2013
Bookmark and Share
Ready to plant: 'Iron Lady' tomato punches out blights.

If the name fits, grow it: "Iron Lady" is the first tomato to resist three major fungal diseases - early blight, late blight and Septoria leaf spot - plaguing New York's growers for years.

For farmers, this new tomato dramatically reduces the need for expensive fungicide.

Iron Lady is available to both producers and home gardeners for the upcoming growing season.

Favoring the Northeast's moist, cool conditions, one or more of these diseases occurs yearly, prompting Martha Mutschler-Chu, Cornell professor of plant breeding and genetics, to create tomatoes that resist late blight and early blight.

However, since those plants could still be defoliated by Septoria leaf spot, Mutscher-Chu worked with research associate Stella Zitter and plant pathologist Tom Zitter to create Septoria resistance.

Experimental hybrids using these "triple blight resistant" tomatoes were successfully grown in trials in North Carolina, West Virginia, Virginia and New York, in a project supported by the Northeast Regional Integrated Pest Management Center.

"We have demonstrated that we have tomato hybrids with good medium fruit that will stand up to these diseases," Mutschler-Chu said. "In order to reduce the need for fungicides, you need to genetically control all three diseases."

Iron Lady, the cross of a "triple resistant" Cornell line and a late blight/early blight line from North Carolina State University, is the first of these hybrids to become commercially available, via High Mowing Organic Seeds.

In addition to the strongest possible resistance to late blight - provided by the combination of two genes, Ph2 and Ph3 - tolerance to early blight and resistance to Septoria leaf spot, the plant also has resistances to verticillium and fusarium wilts, common to most modern tomato varieties.

Early blight tolerance is not as strong as resistance, so the need for fungicides may not be completely eliminated.

But Mutschler-Chu teamed up with professor Tom Zitter to identify a complementary fungicide strategy with the lowest possible environmental impact.

This led to a potential reduction of sprays from weekly application to once or twice a season. That information is available to growers via Cornell's Vegetable MD website.

"Tolerance alone is not enough, spray alone is not enough, but together there is good synergy," Mutschler-Chu said.

Iron Lady is suitable for organic production, and was tested by organic farmers as part of a federal Organic Agriculture Research and Extension-funded project coordinated by Cornell breeder Michael Mazourek.

He said disease-resistant tomatoes were identified as a top priority for organic growers, who currently use copper to control blight, a solution that can be just as bad for the environment as chemical fungicides.

"This represents a really valuable tool for growers," Mazourek said. "And the tomatoes are head and shoulders above those you would find shipped to the grocery store."

Mutschler-Chu said she wanted to make Iron Lady available to growers quickly because of the real and immediate need. "We have even better lines coming along," she said. "We are testing second-generation hybrids now."

While breeding the new lines, Mutschler-Chu and her team created molecular markers that can be used to detect the presence of Ph2 and Ph3 in plants.

"Use of markers cuts in half the number of generations it takes to breed," she said. "Development of a similar marker for the Septoria resistance gene is nearing completion."

Mutschler-Chu is sharing her discoveries with scientists and seed companies, so that the resistance traits can be incorporated into other varieties.

This project was supported in part by a New York Specialty Crop grant.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cancer Cells 'Talk' to their Environment, and it Talks Back
Scientists from Cornell University have developed a novel microscopy technique to measure the force breast cancer cells exert on their surroundings.
Wednesday, November 23, 2016
Wicked Weeds May Be Agricultural Angels
Agricutural scientists suggest less control over nature, as weeds can be beneficial to agriculture.
Wednesday, November 16, 2016
Bad Mitochondrial DNA May Increase Risk of Autism in Kids
Researchers have confired a genetic link between mtDNA and certain forms of autism spectrum disorder.
Tuesday, November 01, 2016
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Friday, September 30, 2016
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Friday, September 02, 2016
Vortex Ring Freezing Applications
Accidental lab discovery could aid cell delivery and cell-free protein production.
Monday, August 22, 2016
Measuring Chemistry on a Chip
Researchers developing chemical sensor chip for sample analysis in a lab or monitoring air and water quality in the field.
Thursday, August 18, 2016
Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
Wednesday, June 29, 2016
Pathogen Takes Control of Gypsy Moth Populations
A new fungal pathogen is killing gypsy moth caterpillars and crowding out communities of pathogens and parasites that previously destroyed these moth pests.
Tuesday, April 26, 2016
Eating Green Could be in Your Genes
Genetic variation uncovered that has evolved in populations that have historically favored vegetarian diets, such as in India, Africa and parts of East Asia.
Friday, April 01, 2016
$4.8M USAID Grant to Improve Food Security
To strengthen capacity to develop and disseminate genetically engineered eggplant in Bangladesh and the Philippines, the USAID has awarded Cornell a $4.8 million, three-year cooperative grant.
Friday, April 01, 2016
Proteins Seek, Attack, Destroy Tumor Cells in Bloodstream
Using white blood cells to ferry potent cancer-killing proteins through the bloodstream virtually eliminates metastatic prostate cancer in mice, Cornell researchers have confirmed.
Friday, January 15, 2016
Tumor-suppressing Gene Lends Insight to Cancer Treatment
Researchers have found that delicate replication process derails if a gene named PTEN has mutated or is absent.
Tuesday, July 14, 2015
Synthetic Immune Organ Produces Antibodies
Cornell engineers have created a functional, synthetic immune organ that produces antibodies and can be controlled in the lab, completely separate from a living organism.
Friday, June 12, 2015
On Planes, Savory Tomato Becomes Favored Flavor
Study shows the effect that airplane noise has on passengers' taste preferences.
Friday, May 15, 2015
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Transporting Microscopic Cargo Between Human Cells
Scientists have developed a virus-inspired delivery system for material transport between cells.
Tissue Damage Is Key for Cell Reprogramming
Researchers have shown tissue damage is important for cells to return to an embryonic state for cell reprogramming.
Metabolite Promotes Cancer Cell Transformation
Researchers have identified a metabolite that promotes cancer cell transformation and colorectal cancer spread.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Bird Flu Confirmed in the Netherlands
An outbreak of H5 avian influenza was confirmed in the Flevoland province of the Netherlands.
Pasteurised Bacterium Reduces Obesity and Diabetes
Researchers have discovered that an intestinal bacterium provides a lasting effect on the intestinal barrier.
Turning Off Asthma Attacks
Researchers discover a critical cellular “off” switch for the inflammatory immune response that causes asthma attacks.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!